Correlation Between Qualigen Therapeutics and Ushio
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Ushio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Ushio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Ushio Inc, you can compare the effects of market volatilities on Qualigen Therapeutics and Ushio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Ushio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Ushio.
Diversification Opportunities for Qualigen Therapeutics and Ushio
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Qualigen and Ushio is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Ushio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ushio Inc and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Ushio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ushio Inc has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Ushio go up and down completely randomly.
Pair Corralation between Qualigen Therapeutics and Ushio
Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Ushio. In addition to that, Qualigen Therapeutics is 15.55 times more volatile than Ushio Inc. It trades about -0.05 of its total potential returns per unit of risk. Ushio Inc is currently generating about -0.19 per unit of volatility. If you would invest 1,423 in Ushio Inc on September 5, 2024 and sell it today you would lose (23.00) from holding Ushio Inc or give up 1.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Qualigen Therapeutics vs. Ushio Inc
Performance |
| Timeline |
| Qualigen Therapeutics |
| Ushio Inc |
Qualigen Therapeutics and Ushio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Qualigen Therapeutics and Ushio
The main advantage of trading using opposite Qualigen Therapeutics and Ushio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Ushio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ushio will offset losses from the drop in Ushio's long position.| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
| Ushio vs. Dear Cashmere Holding | Ushio vs. Goff Corp | Ushio vs. Wialan Technologies | Ushio vs. Cgrowth Capital |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |